论文部分内容阅读
目的:评价磁共振成像MRI在AS疾病活动度检测中的效果,以便其更好的在临床中应用。方法:给予符合国际脊柱关节炎评估协会ASAS制订的中轴型脊柱关节炎分类标准的40例AS患者使用甲氨蝶呤联合柳氮磺胺吡啶进行治疗,并分别在0、4、8、12、16、20周采用疾病活动性评价指数调查表(BASDAI)和骶髂关节MRI炎症评分对患者治疗后疾病活动度进行评价。结果:除了第4周BASDAI和MRI炎症评分两种评价方法的评价结果有差异外,其余阶段的评价结果均一致。结论:MRI炎症评分和目前应用比较广泛的评分机制的评分结果基本一致,可以在临床中应用。
OBJECTIVE: To evaluate the effect of magnetic resonance imaging (MRI) in the detection of AS disease activity in order to better its application in clinical practice. Methods: Forty patients with AS who met the classification criteria of axial spondyloarthritis by ASAS were treated with methotrexate and sulfasalazine, and were treated with 0, 4, 8, 12, At 16 and 20 weeks, the patients’ disease activity was assessed by BASDAI and MRI scores of sacroiliac joint MRI. Results: The evaluation results of BASDAI and MRI were the same except the difference between the two evaluation methods at the 4th week. Conclusion: MRI scoring system is basically the same as scoring system of the most widely used scoring system and can be applied in clinical practice.